A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.

The global Prokinetic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Prokinetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokinetic Drug.

Report Scope

The Prokinetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prokinetic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prokinetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prokinetic Drug Market Report

Report Metric	Details
Report Name	Prokinetic Drug Market
CAGR	5%
Segment by Type	Metoclopramide Domperidone Cisapride Others
Segment by Application	Gastroparesis Constipation Reflux Esophagitis Functional Dyspepsia
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals, Hanmi Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prokinetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prokinetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prokinetic Drug Market report?

Ans: The main players in the Prokinetic Drug Market are Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals, Hanmi Pharm

What are the Application segmentation covered in the Prokinetic Drug Market report?

Ans: The Applications covered in the Prokinetic Drug Market report are Gastroparesis, Constipation, Reflux Esophagitis, Functional Dyspepsia

What are the Type segmentation covered in the Prokinetic Drug Market report?

Ans: The Types covered in the Prokinetic Drug Market report are Metoclopramide, Domperidone, Cisapride, Others

1 Prokinetic Drug Market Overview

1.1 Product Overview and Scope of Prokinetic Drug

1.2 Prokinetic Drug Segment by Type

1.2.1 Global Prokinetic Drug Market Value Comparison by Type (2024-2030)

1.2.2 Metoclopramide

1.2.3 Domperidone

1.2.4 Cisapride

1.2.5 Others

1.3 Prokinetic Drug Segment by Application

1.3.1 Global Prokinetic Drug Market Value by Application: (2024-2030)

1.3.2 Gastroparesis

1.3.3 Constipation

1.3.4 Reflux Esophagitis

1.3.5 Functional Dyspepsia

1.4 Global Prokinetic Drug Market Size Estimates and Forecasts

1.4.1 Global Prokinetic Drug Revenue 2019-2030

1.4.2 Global Prokinetic Drug Sales 2019-2030

1.4.3 Global Prokinetic Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Prokinetic Drug Market Competition by Manufacturers

2.1 Global Prokinetic Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Prokinetic Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Prokinetic Drug Average Price by Manufacturers (2019-2024)

2.4 Global Prokinetic Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Prokinetic Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Prokinetic Drug, Product Type & Application

2.7 Prokinetic Drug Market Competitive Situation and Trends

2.7.1 Prokinetic Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Prokinetic Drug Players Market Share by Revenue

2.7.3 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Prokinetic Drug Retrospective Market Scenario by Region

3.1 Global Prokinetic Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Prokinetic Drug Global Prokinetic Drug Sales by Region: 2019-2030

3.2.1 Global Prokinetic Drug Sales by Region: 2019-2024

3.2.2 Global Prokinetic Drug Sales by Region: 2025-2030

3.3 Global Prokinetic Drug Global Prokinetic Drug Revenue by Region: 2019-2030

3.3.1 Global Prokinetic Drug Revenue by Region: 2019-2024

3.3.2 Global Prokinetic Drug Revenue by Region: 2025-2030

3.4 North America Prokinetic Drug Market Facts & Figures by Country

3.4.1 North America Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Prokinetic Drug Sales by Country (2019-2030)

3.4.3 North America Prokinetic Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Prokinetic Drug Market Facts & Figures by Country

3.5.1 Europe Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Prokinetic Drug Sales by Country (2019-2030)

3.5.3 Europe Prokinetic Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Prokinetic Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Prokinetic Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Prokinetic Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Prokinetic Drug Market Facts & Figures by Country

3.7.1 Latin America Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Prokinetic Drug Sales by Country (2019-2030)

3.7.3 Latin America Prokinetic Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Prokinetic Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Prokinetic Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Prokinetic Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Prokinetic Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Prokinetic Drug Sales by Type (2019-2030)

4.1.1 Global Prokinetic Drug Sales by Type (2019-2024)

4.1.2 Global Prokinetic Drug Sales by Type (2025-2030)

4.1.3 Global Prokinetic Drug Sales Market Share by Type (2019-2030)

4.2 Global Prokinetic Drug Revenue by Type (2019-2030)

4.2.1 Global Prokinetic Drug Revenue by Type (2019-2024)

4.2.2 Global Prokinetic Drug Revenue by Type (2025-2030)

4.2.3 Global Prokinetic Drug Revenue Market Share by Type (2019-2030)

4.3 Global Prokinetic Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Prokinetic Drug Sales by Application (2019-2030)

5.1.1 Global Prokinetic Drug Sales by Application (2019-2024)

5.1.2 Global Prokinetic Drug Sales by Application (2025-2030)

5.1.3 Global Prokinetic Drug Sales Market Share by Application (2019-2030)

5.2 Global Prokinetic Drug Revenue by Application (2019-2030)

5.2.1 Global Prokinetic Drug Revenue by Application (2019-2024)

5.2.2 Global Prokinetic Drug Revenue by Application (2025-2030)

5.2.3 Global Prokinetic Drug Revenue Market Share by Application (2019-2030)

5.3 Global Prokinetic Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sumitomo

6.1.1 Sumitomo Corporation Information

6.1.2 Sumitomo Description and Business Overview

6.1.3 Sumitomo Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sumitomo Prokinetic Drug Product Portfolio

6.1.5 Sumitomo Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Corporation Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Johnson & Johnson Prokinetic Drug Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Prokinetic Drug Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Kyowa Kirin Pharmaceuticals

6.4.1 Kyowa Kirin Pharmaceuticals Corporation Information

6.4.2 Kyowa Kirin Pharmaceuticals Description and Business Overview

6.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Product Portfolio

6.4.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Corporation Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Pfizer Prokinetic Drug Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Teva Prokinetic Drug Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Cadila Pharmaceuticals

6.6.1 Cadila Pharmaceuticals Corporation Information

6.6.2 Cadila Pharmaceuticals Description and Business Overview

6.6.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Cadila Pharmaceuticals Prokinetic Drug Product Portfolio

6.7.5 Cadila Pharmaceuticals Recent Developments/Updates

6.8 Hanmi Pharm

6.8.1 Hanmi Pharm Corporation Information

6.8.2 Hanmi Pharm Description and Business Overview

6.8.3 Hanmi Pharm Prokinetic Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Hanmi Pharm Prokinetic Drug Product Portfolio

6.8.5 Hanmi Pharm Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Prokinetic Drug Industry Chain Analysis

7.2 Prokinetic Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Prokinetic Drug Production Mode & Process

7.4 Prokinetic Drug Sales and Marketing

7.4.1 Prokinetic Drug Sales Channels

7.4.2 Prokinetic Drug Distributors

7.5 Prokinetic Drug Customers

8 Prokinetic Drug Market Dynamics

8.1 Prokinetic Drug Industry Trends

8.2 Prokinetic Drug Market Drivers

8.3 Prokinetic Drug Market Challenges

8.4 Prokinetic Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sumitomo

Johnson & Johnson

Sanofi

Kyowa Kirin Pharmaceuticals

Pfizer Inc

TEVA

Cadila Pharmaceuticals

Hanmi Pharm

List of Tables

Table 1. Global Prokinetic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Prokinetic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Prokinetic Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Prokinetic Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Prokinetic Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Prokinetic Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Prokinetic Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Prokinetic Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Prokinetic Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Prokinetic Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Prokinetic Drug, Product Type & Application

Table 12. Global Key Manufacturers of Prokinetic Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Prokinetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prokinetic Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Prokinetic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Prokinetic Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Prokinetic Drug Sales Market Share by Region (2019-2024)

Table 19. Global Prokinetic Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Prokinetic Drug Sales Market Share by Region (2025-2030)

Table 21. Global Prokinetic Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Prokinetic Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Prokinetic Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Prokinetic Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Prokinetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Prokinetic Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Prokinetic Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Prokinetic Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Prokinetic Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Prokinetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Prokinetic Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Prokinetic Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Prokinetic Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Prokinetic Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Prokinetic Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Prokinetic Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Prokinetic Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Prokinetic Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Prokinetic Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Prokinetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Prokinetic Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Prokinetic Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Prokinetic Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Prokinetic Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Prokinetic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Prokinetic Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Prokinetic Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Prokinetic Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Prokinetic Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Prokinetic Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Prokinetic Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Prokinetic Drug Sales Market Share by Type (2019-2024)

Table 53. Global Prokinetic Drug Sales Market Share by Type (2025-2030)

Table 54. Global Prokinetic Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Prokinetic Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Prokinetic Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Prokinetic Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Prokinetic Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global Prokinetic Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global Prokinetic Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Prokinetic Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Prokinetic Drug Sales Market Share by Application (2019-2024)

Table 63. Global Prokinetic Drug Sales Market Share by Application (2025-2030)

Table 64. Global Prokinetic Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Prokinetic Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Prokinetic Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Prokinetic Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Prokinetic Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global Prokinetic Drug Price (US$/Unit) by Application (2025-2030)

Table 70. Sumitomo Corporation Information

Table 71. Sumitomo Description and Business Overview

Table 72. Sumitomo Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Sumitomo Prokinetic Drug Product

Table 74. Sumitomo Recent Developments/Updates

Table 75. Johnson & Johnson Corporation Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Johnson & Johnson Prokinetic Drug Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi Prokinetic Drug Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Kyowa Kirin Pharmaceuticals Corporation Information

Table 86. Kyowa Kirin Pharmaceuticals Description and Business Overview

Table 87. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product

Table 89. Kyowa Kirin Pharmaceuticals Recent Developments/Updates

Table 90. Pfizer Corporation Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Pfizer Prokinetic Drug Product

Table 94. Pfizer Recent Developments/Updates

Table 95. Teva Corporation Information

Table 96. Teva Description and Business Overview

Table 97. Teva Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Teva Prokinetic Drug Product

Table 99. Teva Recent Developments/Updates

Table 100. Cadila Pharmaceuticals Corporation Information

Table 101. Cadila Pharmaceuticals Description and Business Overview

Table 102. Cadila Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Cadila Pharmaceuticals Prokinetic Drug Product

Table 104. Cadila Pharmaceuticals Recent Developments/Updates

Table 105. Hanmi Pharm Corporation Information

Table 106. Hanmi Pharm Description and Business Overview

Table 107. Hanmi Pharm Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Hanmi Pharm Prokinetic Drug Product

Table 109. Hanmi Pharm Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Prokinetic Drug Distributors List

Table 113. Prokinetic Drug Customers List

Table 114. Prokinetic Drug Market Trends

Table 115. Prokinetic Drug Market Drivers

Table 116. Prokinetic Drug Market Challenges

Table 117. Prokinetic Drug Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Prokinetic Drug

Figure 2. Global Prokinetic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Prokinetic Drug Market Share by Type in 2023 & 2030

Figure 4. Metoclopramide Product Picture

Figure 5. Domperidone Product Picture

Figure 6. Cisapride Product Picture

Figure 7. Others Product Picture

Figure 8. Global Prokinetic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Prokinetic Drug Market Share by Application in 2023 & 2030

Figure 10. Gastroparesis

Figure 11. Constipation

Figure 12. Reflux Esophagitis

Figure 13. Functional Dyspepsia

Figure 14. Global Prokinetic Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Prokinetic Drug Market Size (2019-2030) & (US$ Million)

Figure 16. Global Prokinetic Drug Sales (2019-2030) & (K Units)

Figure 17. Global Prokinetic Drug Average Price (US$/Unit) & (2019-2030)

Figure 18. Prokinetic Drug Report Years Considered

Figure 19. Prokinetic Drug Sales Share by Manufacturers in 2023

Figure 20. Global Prokinetic Drug Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Prokinetic Drug Players: Market Share by Revenue in 2023

Figure 22. Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Prokinetic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Prokinetic Drug Sales Market Share by Country (2019-2030)

Figure 25. North America Prokinetic Drug Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Prokinetic Drug Sales Market Share by Country (2019-2030)

Figure 29. Europe Prokinetic Drug Revenue Market Share by Country (2019-2030)

Figure 30. Germany Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Prokinetic Drug Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Prokinetic Drug Revenue Market Share by Region (2019-2030)

Figure 37. China Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Prokinetic Drug Sales Market Share by Country (2019-2030)

Figure 48. Latin America Prokinetic Drug Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Prokinetic Drug Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Prokinetic Drug Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Prokinetic Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Prokinetic Drug by Type (2019-2030)

Figure 58. Global Revenue Market Share of Prokinetic Drug by Type (2019-2030)

Figure 59. Global Prokinetic Drug Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Prokinetic Drug by Application (2019-2030)

Figure 61. Global Revenue Market Share of Prokinetic Drug by Application (2019-2030)

Figure 62. Global Prokinetic Drug Price (US$/Unit) by Application (2019-2030)

Figure 63. Prokinetic Drug Value Chain

Figure 64. Prokinetic Drug Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-24G3922

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Muscle Relaxants Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28K7363

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Drugs for Short Bowel Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19D6153

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Ischemic Cerebral Stroke Prevention Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-35V13407

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Prokinetic Drug Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-27V8237

Global Prokinetic Drug Market Research Report 2024

FEATURED COMPANIES

Prokinetic Drug Market Size

Prokinetic Drug Market

Report Scope

Scope of Prokinetic Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Prokinetic Drug Market report?

What are the Application segmentation covered in the Prokinetic Drug Market report?

What are the Type segmentation covered in the Prokinetic Drug Market report?

FEATURED COMPANIES

RELATED REPORTS